PHILIP MORRIS INTERNATIONAL (NYSE:PM) Presents a High-Quality Technical Breakout Setup
UBS Lifts Philip Morris International (PM) Price Target by $14
Altria vs. Philip Morris International: Tobacco Still Makes a Great Stock. Which Is a Better Buy in 2026?
PMI U.S. Unveils the ZYN America250 Art Series, Bringing Modern Culture to Limited-Edition Cases
Philip Morris’ Smoke-Free Products Are Winning With Regulators. They’ll Win With Investors Too.
Philip Morris’ Safer Products Are Winning With Regulators. They’ll Win With Investors Too.
Philip Morris International (PM) Wins First FDA Modified Risk Nod For ZYN Pouches
UBS Maintains Neutral on Philip Morris Intl, Raises Price Target to $182
FDA Authorizes Lower Disease Risk Claim for Select Philip Morris Zyn Nicotine Pouches
Zyn’s New ‘Lower Risk’ Label Could Give It an Edge Over Rival Nicotine Pouches
FDA clears PM’s Zyn to market as lower cancer risk than cigarettes in 20 variants
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products
Altria vs. Philip Morris International: Which Consumer Goods Stock Is a Better Buy in 2026?
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes
Americans Are Losing Patience with Innovation That Doesn't Make Life Better, New Poll from PMI U.S. Finds
What to Expect From Philip Morris' Q2 2026 Earnings Report
Philip Morris International and Maestro Andrea Bocelli Present "Believe. Further"
Philip Morris, Other Tobacco Stocks Rise After FDA Proposes Foreign Tobacco Regulations
Morgan Stanley and Stifel Raise Confidence in Philip Morris (PM) Ahead of ZYN Ultra Launch and IQOS Expansion
Philip Morris International (PM) Stock After 11.5% YTD Gain Are Valuation Concerns Justified
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.